✦ LIBER ✦

Botulinum toxin as a treatment for tardive dyskinesia

✍ Scribed by Peter N. van Harten; Ad Hovestadt

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 45 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20904

No coin nor oath required. For personal study only.

✦ Synopsis

Two older female patients with a history of psychotic depression were treated with a combination of an antipsychotic and an antidepressant. Both developed persistent tardive dyskinesia with severe tongue protrusion. Botulinum toxin was injected into the genioglossal area and the embarrassing tongue protrusion practically disappeared. Both patients chose to continue taking botulinum toxin.

📜 SIMILAR VOLUMES

Improvement of orolingual dyskinesia as

Improvement of orolingual dyskinesia as a remote effect of botulinum toxin

✍ Asunción Ávila; Plácida Maho; Juan Bello 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Comparison of treatment of tardive dysto

Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A

✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo

Treatment of facial and orolinguomandibu

Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin a: Evidence of a long-lasting effect

✍ Petr Kañovský; Hana Streitová; Martin Bares̃; Hana Hortová 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

Treatment of spasticity with botulinum t

Treatment of spasticity with botulinum toxin

✍ G. E. Borodic; R. Ferrante; A. W. Wiegner; R. R. Young 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Frey syndrome : Treatment with type A bo

Frey syndrome : Treatment with type A botulinum toxin

✍ Jens J. von Lindern; Bernd Niederhagen; Stefan Bergé; Georg Hägler; Rudolf H. Re 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 1 views

## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li

Search for a Susceptibility Locus to Tar

Search for a Susceptibility Locus to Tardive Dyskinesia

✍ TOSHIYA INADA; IZUMI DOBASHI; TETSUYOSHI SUGITA; ATARU INAGAKI; YOSHIE KITAO; GE 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

In order to ®nd a genetic marker for vulnerability to tardive dyskinesia (TD), we looked for an association between vulnerability to TD and polymorphic sites in the gene loci encoding the dopamine D2 receptor (Nco I site), the dopamine D3 receptor (Bal I site), and the dopamine transporter (40-bp, t